HIV and Hepatitis.com Coverage of the
14th Annual Conference on Retroviruses
and Opportunistic Infections (14th CROI)
February 25 - 28, 2007, Los Angeles, CA
Therapy for Treatment-naÏve Patients

Once-Daily Lopinavir/ritonavir (Kaletra) and Nevirapine (Viramune) Demonstrate Suboptimal Efficacy in Some Patients  - 3/16/07

Risk of TB-associated Immune Reconstitution Disease Is High in South African Patients Initiating Antiretroviral Therapy with Low Baseline CD4 Cell Counts  - 3/16/07

Tenofovir Regimens Show Greater Virologic Suppression in Treatment-naïve Blacks Compared to Thymidine Analog Regimens  - 3/09/07

Two Studies Disagree about Benefits of Early Antiretroviral Therapy  - 3/09/07

Integrase Inhibitor GSK364735 is Safe and Well-tolerated in Phase I Study  - 3/06/07













































14th croi